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Abstract Microparticles are membrane-derived vesicles
that are released from cells during activation or cell death.
These particles can serve as mediators of intercellular cross-
talk and induce a variety of cellular responses. Previous
studies have shown that macrophages undergo apoptosis af-
ter phagocytosing microparticles. Here, we have addressed
the hypothesis that microparticles trigger this process via
lipid pathways. In these experiments, microparticles induced
apoptosis in primary macrophage cells or cell lines (RAW
264.7 or U937) with up to a 5-fold increase. Preincubation
of macrophages with phosphatidylinositol-3,5-bisphosphate
(PtdIns(3,5)BP) reduced the microparticle-induced apopto-
sis in a dose-dependent manner. PtdIns(3,5)BP is a specific
inhibitor of the acid sphingomyelinase and thus can block
the generation of pro-apoptotic ceramides. Similarly, the pre-
incubation of macrophages with PtdIns(3,5)BP prevented
microparticle-induced upregulation of caspase 8, which is
a major target molecule of ceramide action in the apopto-
sis pathway. PtdIns(3,5)BP, however, had no effect on the
spontaneous rate of apoptosis. To evaluate further signaling
pathways induced by microparticles, the extracellular sig-
nal regulated kinase (ERK-) 1 was investigated. This kinase
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plays a role in activating phospholipases A2 which cleaves
membrane phospholipids into arachidonic acid; microparti-
cles have been suggested to be a preferred substrate for phos-
pholipases A2. As shown in our experiments, microparticles
strongly increased the amount of phosphorylated ERK1/2
in RAW 264.7 macrophages in a time-dependent manner,
peaking 15 min after co-incubation. Addition of PD98059, a
specific inhibitor of ERK1, prevented the increase in apopto-
sis of RAW 264.7 macrophages. Together, these data suggest
that microparticles perturb lipid homeostasis of macrophages
and thereby induce apoptosis. These results emphasize the
importance of biolipids in the cellular cross-talk of immune
cells. Based on the fact that in clinical situations with exces-
sive cell death such as malignancies, autoimmune diseases
and following chemotherapies high levels of circulating mi-
croparticles might modulate phagocytosing cells, a suppres-
sion of the immune response might occur due to loss of
macrophages.
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Introduction
Microparticles are subcellular vesicles that are released from
cells by shedding of membraneous blebs. The release of these
structures is strongly increased when cells are exposed to pro-
inflammatory or pro-apoptotic stimuli [1–3]. Consistent with
a role of microparticles in the pathogenesis of inflammatory
diseases, levels of these structures are elevated in autoim-
mune diseases such as rheumatoid arthritis [4], vasculitis
[5], lupus anticoagulant syndrome [6], and multiple scle-
rosis [7]. These findings implicate microparticles as novel
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mediators of inflammation and suggest that the release of
microparticles and their biological activities can be targeted
in new approaches to immune modulation [8].
As shown by in vitro studies, microparticles can function
as subcellular vectors to deliver proteins and lipids into tar-
get cells. This transfer can alter the phenotypic properties
of the target cell as well as induce a variety of functional
changes [9]. Recently, we have shown that microparticles
derived from human Jurkat T-lymphoma cells are rapidly en-
gulfed by RAW 264.7 mouse macrophages, which, in turn,
undergo apoptosis [10]. The death of the macrophages leads
to further generation of microparticles, albeit with different
surface markers. While suggesting a mechanism for loss and
functional disturbance of macrophages during inflammation,
the mechanisms of apoptosis induced by the microparticles
were not defined by these experiments.
In this current study, we have therefore explored this death
pathway, focusing on the role of membrane phospholipids
in the effects of microparticles on macrophage viability. In
the induction of apoptosis, lipid metabolism has been impli-
cated as a central event, with the pathway involving arachi-
donic acid and sphingomyelin receiving the most attention
[11–15]. Arachidonic acid, which belongs to the group of es-
sential twenty-carbon fatty acids (eicosanoids), is the most
abundant polyunsaturated fatty acid among the phospholipid
components of cell membranes. Arachidonic acid under-
goes cleavage from membrane phospholipids by isoforms
of phospholipase A2, which cleave the sn-2-acyl position of
1-ether-linked membrane glycerophospholipids to liberate
fatty acids and lysophospholipids [16, 17].
The activity of phospholipase A2 requires a rearrange-
ment of membrane lipids to expose phosphatidylserine on
the external layer [18].
Shed from stimulated or dying cells, microparticles lose
membrane asymmetry with subsequent surface exposure of
aminophospholipids [19, 20]. These findings suggest that
these structures could provide a substrate for phospholipases
that is preferentially cleaved [21]. In this scenario, the accu-
mulation of free arachidonic acid could enhance the activity
of acid sphingomyelinase [22–25] to catalyze the conversion
of sphingomyelin to cellular (C2/C16)-ceramides. With an
increased concentration of ceramide, apoptosis would then
be induced by the activation of caspase 8 and the release
of downstream pro-apoptotic factors [26–28]. Of note, other
phospholipases can degrade phospholipids more efficiently
when sphingomyelinase is present and active [29–31].
Since microparticles consist of a packed phospholipid bi-
layer with altered membrane asymmetry, we have hypothe-
sized that the transfer of a pool of 1-ether-linked phospho-
lipids into target cells occurring during the phagocytosis of
microparticles could perturb cellular arachidonic acid levels.
With activated phospholipase A2, the changes in fatty acid
metabolism could promote apoptosis in cells phagocytos-
ing microparticles. We have therefore investigated the role
of lipid mediators in the induction of macrophage apoptosis
following interaction with microparticles and explored the
effects of a specific inhibitor of syphingomyelinase. Results
presented herein indicate the importance of this enzyme in
the induction of apoptosis and the role of lipid mediators in
cellular cross-talk stimulated by interaction of macrophages
with microparticles.
Materials and methods
Reagents
Arachidonic acid as well as the pan-caspase-inhibitor
Z-VAD-FMK were from Sigma (Sigma Chemical
Co., St. Louis, MO), D-myo-phosphatidylinositol-3,5-
bisphosphate [PtdIns(3,5)P] was purchased from Ech-
elon Biosciences Incorporated (Salt Lake City, UT,
USA). PD098059 (2′-amino-3′-methoxyflavone) was from
Promega (Madison, WI, USA). Phycoerythrin (PE)-
labelled Annexin was from BD Biosciences Pharmin-
gen (San Diego, CA, USA). JC-1 (5,5′,6,6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine Iodide) was
purchased from Calbiochem (San Diego, CA, USA). Cell
Signaling Cytobeads for ERK1/2 and JNK1/2 were from
BD Biosciences Pharmingen.
Cells/cell cultures
Mouse macrophage cell line RAW 264.7 (adherent), human
U937 (non-adherent), and Jurkat T lymphoma cells were
purchased from ATCC (Manassas, VA) and cultured in Dul-
becco’s modified Eagle’s medium (DMEM) (Gibco) con-
taining 2 mmol/l L-glutamine. DMEM was supplemented
with 10% heat-inactivated fetal calf serum (FCS), 15 mmol/l
HEPES, 50 µg/ml streptomycin, 100 U of penicillin, and
2 µl/ml amphotericine B (all from Gibco).
For activation, Jurkat T cells were stimulated with inter-
leukin (IL-)2 (10 ng/ml) and U937 cells were stimulated with
concanavalin (1 µg/ml; both from Sigma Chemical Co., St
Louis, MO) in DMEM with 10% FCS for 12 h. After stimula-
tion, the supernatants were collected and microparticles were
isolated immediately as described previously [32]. For co-
culture experiments, 105 confluent RAW 264.7 macrophages
or 3 × 105 U937 cells were incubated for 6 and 36 h with
freshly isolated microparticles from activated Jurkat T-cells.
The number of cells was determined by the CASY-1 cell
counter (Scha¨rfe System, Reutlingen, Germany).
Phagocytosis of microparticles by RAW macrophages
was prevented by using anopore membrane systems (pore
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size 0.2 µm) as cell culture inserts (Nunc GmbH, Wies-
baden, Germany), on which microparticles resuspended in
PBS were added.
Isolation of primary macrophages
For the isolation of primary macrophages, buffy coats from
healthy donors were obtained from the local blood bank.
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by Ficoll/Hypaque (Pharmacia Biotech) density gradi-
ent centrifugation. After incubation with anti-human CD14-
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany),
primary macrophages were isolated by positive selection
magnetic cell sorting (MACS) according to the manufac-
ture’s instructions. After adding 50 ng/ml GM-CSF at the
initial day of culture, freshly isolated macrophages were cul-
tured in modified Roswell Park Memorial Institute medium
(RPMI 1640, with supplements as described above) for 7
days prior to incubation experiments.
Isolation of Jurkat-derived microparticles
Microparticles were prepared as described previously [32].
Briefly, cell culture supernatants obtained from Jurkat T-cells
stimulated for 12 h were centrifuged at 1500 g for 10 min to
remove suspended cells. Supernatants were then centrifuged
twice at 100,000 g for 20 min at 14◦C by using a Centrikon
T-1065 centrifuge with a TST28.38 head (Kontron Instru-
ments, Munich, Germany). Pelleted microparticles were re-
suspended in phosphate-buffered saline (PBS, pH 7.5). The
microparticles were then either quantified and characterized
by flow cytometry analysis or used for coculture experiments
with RAW 264.7 or U937 cells. The number of micropar-
ticles as counted by FACS was adjusted to the number of
RAW 264.7 or U937 cells, respectively.
FACS
Flow cytometry was performed using a FACScan flow cy-
tometer (Becton Dickinson). A minimum of 10,000 cells
per sample were acquired in list mode and analyzed using
Cell quest software (Becton Dickinson Immunocytometry
System, San Jose, CA).
Detection of apoptosis
Apoptosis was assessed by analyzing Annexin V-binding
properties of membranes, measurement of the mitochon-
drial potential, and caspase 8 activity. Briefly, a total of
1 × 105 RAW macrophages and 3 × 105 human U937 cells
were stimulated with 3 × 106 Jurkat-derived microparticles
as described above. Inhibitor of acid sphingomyelinase was
added in concentrations of 5 and 10 µM. Inhibition of general
caspase activity was achieved by using 50 µM of the pan-
caspase-inhibitor Z-VAD-FMK (Sigma). RAW macrophages
were pre-incubated with Z-VAD-FMK for 1 h before adding
microparticles. After 6 and 36 h, the cells were then exam-
ined for apoptosis. In all apoptosis assays, negative controls
consisted of untreated macrophages.
Annexin staining
1 × 105 cells were examined for apoptosis using Annexin V -
PE according to the manufacturer’s protocol. Briefly, adher-
ent cells were trypsinized, centrifuged at 500 g for 10 min,
and resuspended in 100 µl of FACS binding buffer (BD
Pharmingen, San Diego, CA, USA). Annexin V - PE was
added directly to the cells. After incubation for 15 min at
room temperature, the cells were analyzed by FACS (FAC-
Scalibur, Becton Dickinson Mansfield, MA, USA).
Determination of mitochondrial membrane potential (ϕ)
ϕ was analyzed by a previously described method which
allows the measurement of ϕ in intact cells [33, 34]. Briefly,
JC-1 is a lipophilic cation that can selectively enter into
mitochondria [35]. JC-1 exists in a monomeric form emitting
at 527 nm after excitation at 490 nm; however, depending on
ϕ, JC-1 is able to form J-aggregates that are associated with
a large shift in emission (590 nm) [36, 37]. Thus, the color
of the dye changes reversibly from green to greenish orange
as the mitochondrial membrane becomes more polarized as
a marker of late apoptosis [35]. Both colors can be detected
using filters commonly mounted in flow cytometers, so that
the green emission can be analysed in fluorescence channel 1
(FL1) and the greenish orange emission in channel 2 (FL2).
Cell suspensions were incubated in complete medium with
JC-1 (5 µg/ml) for 10 min at room temperature in the dark.
At the end of the incubation period, the cells were washed
once in cold phosphate-buffered saline (PBS), resuspended
in a total volume of 400 µl and analysed by FACS.
Caspase 8 activity
Cells were examined for apoptosis using a fluorimetric cas-
pase 8 activity detection assay (Biovision, Mountain view,
CA) according the manufacture’s instructions. Briefly, cells
were washed with PBS and resuspended in 50 µl of Cell
Lysis Buffer. After 10 min incubation period on ice, 50 µl
reaction buffer was added to the permeabilized cells. The
cells were then stained with anti-active caspase 8 substrate
(IETD-AFC), incubated for 2 h at 37◦C, and measured us-
ing a microtiter fluorescence reader plate (Witec AG, Biotec,
Littau, Switzerland). Data were analyzed by using KC4 soft-
ware (Bio-Tek Instruments, Vermont, USA).
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Inhibition of acid sphingomyelinase
Acid sphingomyelinase (aSMase) catalyzes the lysoso-
mal degradation of sphingomyelin to phosphorylcholine
and ceramide. Inhibition of aSMase was performed using
L-alpha-phosphatidyl-D-myo-inositol-3,5-bisphosphate (Pt-
dIns3, 5BP), a naturally occurring substance detected in
mammalian, plant and yeast cells, which has been recently
characterized [25]. Ptins3,5BP was used in concentrations of
2–10 µM, which is within the range of the ID50 of
PTins3,5BP as described previously [25]. The effect on cell
viability was determined by trypan blue exclusion. Briefly,
respective concentrations of PtdIns3,5BP were added to
U937 cells. After 6 h and 36 h, 50 µl of cell suspensions
were mixed with 50 µl trypan blue and analysed using the
Neubauer counting chamber. Compared to untreated U937
cells, there was no increase in the number of blue colored
cells.
Analysis of MAP-Kinases activation
Phosphorylation of MAP-K (ERK1/2 and JNK 1/2) was de-
termined by FACS analysis using Cell Signaling Flex Set
assay procedure (BD Biosciences Pharmingen, San Diego,
CA, USA) according the instructions of the manufacturer.
Inhibition of MAP-Kinases (MEK1/ERK1)
Inhibition of MEK1/ERK1 was performed using PD098059,
a selective blocking agent of the activation of MEK1.
PD098059 was used in concentrations of 10 µM, which
is within the range of the ID50 of PD098059 as shown pre-
viously [38]. Trypan blue analysis of cytotoxicity after 6 h
showed no effect on cell viability determined by cell count-
ing.
Statistical analysis
All data are expressed as mean ± standard deviation (SD).
Statistical analysis was performed using the GraphPad Prism
Software, 4.03 (Graph Pad Software Inc., San Diego, CA).
For analysis between different groups the Mann-Whitney test
was used, and a value of p < 0.05 was considered statistical
significant.
Results
Induction of apoptosis in macrophage cells
by microparticles
Previous studies have shown that microparticles released
from Jurkat T-cells are cleared by RAW 264.7 macrophages
and, subsequently, induce apoptosis in these cells in a dose-
dependent manner [10]. Consistent with these findings, mi-
croparticles derived from Jurkat T-cells stimulated with IL-2
induced apoptosis in RAW 264.7 macrophages as determined
by Annexin V staining and FACS analysis 36 h after incuba-
tion. The frequency of spontaneous apoptotic cells in cultures
of RAW 264.7 macrophages was 5.3 ± 1.0%, but this number
was significantly increased to 40.2. ± 7.7% upon incubation
with 3 × 106 Jurkat-derived microparticles. In these exper-
iments, the number of microparticles used was within the
physiological range of levels of circulating microparticles
reported previously [4, 39].
To evaluate whether human macrophages also undergo
apoptosis after incubation with microparticles, microparti-
cles from Jurkat cells were added to 3 × 105 human U937
cells as well as 3 × 105 primary macrophages from healthy
donors. In both conditions, apoptosis was strongly induced
in macrophages 36 h after incubation with microparticles. In
human U937 cells, the induction of apoptosis was less promi-
nent (by about 3 fold from 12.0 ± 3.6% to 35.3 ± 6.0%);
this difference may relate to the lower phagocytotic capacity
of these myeloid precursor cells (Fig. 1). In contrast, cells
without phagocytosing capacity such as dermal and synovial
fibroblasts derived from different diseases did not show an
increased rate of apoptosis upon treatment with microparti-
cles (data not shown). In a next step, we used cell culture
inserts as microfilters to prevent direct contact and phago-
cytosis of microparticles by RAW macrophages. Anopore
filters of 0.2 µm strongly reduced the microparticle-induced
apoptosis by 53.3 ± 4.3% after 36 h as measured by FACS
analysis using Annexin V-PE. These data suggest that ei-
ther direct cell contact and most likely, phagocytosis, is
required to induce apoptosis in RAW 264.7 macrophages
by microparticles. These results were further confirmed
by incubating macrophages with microparticle-free super-
natant that did not change the rate of apoptosis of target
cells.
To explore further mechanisms of macrophage apopto-
sis in this system, we first analyzed whether microparticles
from various origins can induce apoptosis in target cells
to an equivalent extent. We therefore stimulated both Ju-
rkat T-cells and human U937 cells to induce the production
of microparticles. These particles were isolated after 12 h
and then added at a concentration of 3 × 106 to 105 RAW
264.7 macrophages. Six hours after incubation, apoptosis
was measured by FACS analysis using JC-1. With micropar-
ticles from both sources, a strong shift of the fluorescent
signal from greenish-orange (fluorescence (FL-) 1 and FL-2
double-positive) to green (FL1 single-positive) could be ob-
served. This shift was due to depolarising changes of the mi-
tochondrial membrane potential, indicating apoptotic events
in microparticle-stimulated cells compared to untreated con-
trol macrophages. Microparticles from 3 × 106 Jurkat T-cells
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Fig. 1 Induction of apoptosis in RAW 264.7 macrophages upon stim-
ulation with Jurkat-derived microparticles. In untreated RAW 264.7
cells (white bar), a spontaneous apoptosis rate of 5.3 ± 1.0% was mea-
sured. When incubated with 3 × 106 Jurkat-derived microparticles,
RAW 264.7 macrophages showed an increased apoptosis rate of
40.2 ± 7.7% (black bar). Similar results were observed in human 937
cells and in primary macrophages. The apoptosis rate was measured by
FACS analysis using Annexin V-PE
increased the apoptotic RAW 264.7 cell population from 5%
to 14.5 ± 4.4% (Fig. 2a), while microparticles from U937
cells increased apoptosis from 5% to 22.0 ± 1.8% (Fig. 2b).
The effect of inhibiting acid sphingomyelinase
on microparticle-induced apoptosis
Following cell stimulation, isoforms of phospholipase A2
can cleave membrane phospholipids to liberate arachidonic
acid, which, in turn, activates the enzyme acid sphingomyeli-
nase (aSMase) to metabolize sphingomyelin into ceramides.
To investigate whether microparticles activate the apoptotic
program in phagocytes through the arachidonic acid path-
way, RAW 264.7 macrophages were incubated with dif-
ferent concentrations of arachidonic acid for 36 h before
analysis of apoptosis. As shown in Fig. 3, arachidonic acid
dose-dependently induced apoptosis in macrophages, with
maximum effects observed at 100 µM.
To assess the down-stream effects of archidonic acid,
RAW 264.7 macrophages were next pre-incubated for 2 h
with varying concentrations of the specific aSMase-inihibitor
phosphatidylinositol-3,5-biphosphate [Ptins(3,5)BP] [25]
before adding microparticles. Apoptosis was then tested.
Figure 4 shows the effects of Ptins(3,5)BP on macrophages
that were incubated for 6 and 36 h with microparticles. In
these experiments, Ptins(3,5)BP decreased the apoptosis-
inducing effect of microparticles on macrophages in a dose-
dependent manner. Six hours after incubation, Ptins(3,5)BP
reduced the fraction of cells with a depolarised mitochondrial
potential by 36.5 ± 7.6% (5 µM) and by 66 ± 17.8% (10 µM;
p < 0.05) respectively. Similarly, FACS analysis performed
after 36 h showed that the depolarisation of the mitochondrial
potential as seen in early apoptosis could be prevented by
adding Ptins(3,5)BP to RAW 264.7 macrophages that were
incubated with Jurkat—and U937—derived microparticles.
The higher dose of this inhibition produced statistically sig-
nificant inhibition in both experimental conditions. In addi-
tion, RAW macrophages were preincubated with the general
caspase inhibitor Z-VAD-FMK before microparticles were
added. Rates of apoptosis were reduced, in particular when
analysed after 6 h (Fig. 4). These data indicate that the activa-
tion of the phospholipide-ceramide pathway by microparti-
cles results in both caspase-dependent and –independent cell
death with caspases mainly involved during the early stages
of apoptosis.
The effect of Ptins(3,5)BP on the basal rate of apoptosis
Untreated U937 cells showed a frequency of Annexin V-
positive cells of 12.0 ± 3.6% after 36 h of culture. To exclude
the possibility that the observed reduction in the Annexin V-
positive population after co-incubation with microparticles
and Ptins(3,5)BP resulted from a reduction of the sponta-
neous rate of apoptosis, U937 cells were incubated with
medium alone or in combination with different concentra-
tions of Ptins(3,5)BP. Staining with Annexin V and FACS
analysis after 36 h showed no differences in the intensity of
the fluorescent signals between untreated cells and aSMase-
inhibited cells at any concentration. In addition, the treatment
with Ptins(3,5)BP had no toxic effects on cells at the con-
centrations used in the study, as measured by trypan blue
exclusion (see experimental procedures).
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Fig. 2 Induction of apoptosis in RAW 264.7 macrophages upon stim-
ulation with microparticles. RAW macrophages were incubated with
microparticles from Jurkat T-cells and human U937 cells. Apoptosis
rate was measured by FACS analysis after 6 h using JC-1. The up-
per panels show the mitochondrial membrane potential of untreated
control cells. The lower panels are as follows: (a) changes in the mito-
chondrial potential (ϕ) indicating an increase of apoptosis upon incu-
bation with Jurkat-derived microparticles from 5% to 14.5 ± 4.4%; (b)
changes in the mitochondrial potential (ϕ) indicating an increase of
apoptosis upon incubation with U937-derived microparticles from 5%
to 22.0 ± 1.8%
The effects of microparticles on caspase 8 activity
in macrophage target cells
Arachidonic acid activates the enzyme acid sphingomyeli-
nase (aSMase) leading to the generation of ceramides. A ma-
jor target molecule of ceramide action is caspase 8, which, in
turn, cleaves the pro-apoptotic factor bid into its active con-
formation. The next series of experiments investigated the
role of microparticles in downstream activation of caspase 8.
Stimulation of RAW 264.7 macrophages with Jurkat-derived
microparticles showed a strong activation of caspase 8 as de-
termined by fluorimetric analysis after 36 h (Fig. 5). Basal
rate was determined by measuring the caspase 8 activity of
unstimulated cells.
To explore these mechanisms further, we investigated
the effect of Ptins(3,5)BP on 105 RAW 264.7 macrophages
when co-incubated with 3 × 106 Jurkat-derived micropar-
ticles. The addition of microparticles increased the basal
enzymatic activity of caspase 8 by 33 ± 6% from 3568 ± 5
relative fluorescence units (RFU) to 4517 ± 621. Similar to
the results of our previous experiments, Ptins(3,5)BP pre-
vented the activation of caspase 8 in a dose-dependent man-
ner. Co-incubation of macrophages with microparticles and
PtdIns(3,5)BP showed a caspase 8 activity of 4060 ± 368
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acid on apoptosis of
macrophages. Arachidonic acid
dose-dependently induced
apoptosis in RAW macrophages.
Macrophages were incubated
with medium alone (white bar),
or incubated with different
concentrations of arachidonic
acid (1–100 µM). Changes of
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after 36 h
Fig. 4 Inhibitory effects of Ptins(3, 5)BP on microparticle-induced
apoptosis. Ptins(3, 5)BP prevented the microparticle-induced depolar-
isation of the mitochondrial membrane in a dose dependent manner.
Phagocytes were incubated with medium alone (white bars), or incu-
bated with 3 × 106 microparticles (black bars) and treated with different
concentrations of Ptins(3,5)BP. Preincubation with the pan-caspase in-
hibitor Z-VAD-FMK (50 µM) before adding microparticles (dashed
bars). Changes of the mitochondrial potential were measured by FACS
using JC-1 after 6 (left side) and 36 h (right side)
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Fig. 5 Ptins(3, 5)BP prevents microparticle-induced up-regulation of
caspase 8. The basal activity of caspase 8 was determined in untreated
macrophages and reached a level of 3500 ± 5 relative fluorescence
units (RFU). Addition of 3 × 106 microparticles increased caspase 8
activity by 33 ± 6% to 4517 ± 621 RFU, whereas pre-incubation of
macrophages with PtdIns(3, 5)BP prevented the microparticle-induced
up regulation of caspase 8 after 36 h in a dose-dependent manner
(4060 ± 368 by using 5 µM, and 3539 ± 196 RFU by using 10 µM)
RFU by using 5 µM and 3539 ± 196 RFU by using 10 µM
PtdIns(3,5)BP (p < 0.05), respectively.
The effects of microparticles on MAP-Kinases
Microparticles have been suggested to be a preferred sub-
strate for phospholipases A2, which cleave membrane
phospholipids into arachidonic acid [14]. Several members
of the MAP-Kinase pathway, in particular the extracellular
signal regulated kinase (ERK-)1, play an important role in
activating phospholipases A2. Thus, we tested the effects
of microparticles on these downstream signalling events.
When analysed by FACS using Cytobeads, 3 × 106 Jurkat-
derived microparticles strongly increased the amount of
phosphorylated ERK1/2 in RAW 264.7 macrophages from
63.2 ± 30.4% to 286.6 ± 51.7% in a time-dependent man-
ner, peaking 15 minutes after co-incubation (Fig. 6). Sim-
ilar results were observed for other members of the MAP-
Kinase pathway (i.e. JNK1/2), although to a lesser extent.
Subsequently, we added PD98059, a specific inhibitor of
ERK1, to RAW macrophages exposed to microparticles.
PD98059 resulted in an abrogation (27.7 ± 4.2%) of the
apoptosis-promoting effects of Jurkat-derived microparticles
in RAW 264.7 cells as assessed 6 h after incubation by FACS
analysis.
To exclude the possibility that the observed reduction in
the Annexin V—positive population after co-incubation with
microparticles and PD098059 resulted from a reduction of
the spontaneous rate of apoptosis, U937 cells were incubated
with various concentrations of PD098059 alone. Analysis of
Annexin V positive cells after 6 h showed no differences
between untreated cells and MEK1/ERK1-inhibited cells.
Furthermore, the treatment with Ptins(3,5)BP had no effects
on cell viability at the concentrations used in the study, as
measured by trypan blue exclusion (see experimental proce-
dures). Together, these findings indicate a role of ceramide
acting via MAP-Kinases in the induction of apoptosis by
microparticles.
Discussion
Results of these studies provide new insight into the bio-
logical activities of microparticles and demonstrate a role of
lipids in the apoptosis-inducing effects of these structures.
Thus, we have shown that microparticles preparations de-
rived from activated cell lines induce the apoptosis program
in RAW 264.7 macrophages [10]. This induction occurred
with microparticles derived both Jurkat and U937 cells, sug-
gesting a common mechanism for the induction of apoptosis.
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Fig. 6 Activation of
MAP-Kinases by
microparticles. Basal levels of
phosphorylated ERK1/2 and
JNK1/2 were measured in
untreated RAW macrophages.
Addition of 3 × 106
Jurkat-derived microparticles
increased levels of
phosphorylated ERK1/2 from
63.2 ± 30.4% to 286.6 ± 51.7%
(mean fluorescence intensity) in
a time-dependent manner.
Similar effects were observed
for JNK1/2
Since microfilters strongly reduced the microparticle-
induced apoptosis, cell-cell contact, most likely involving
phagocytosis, may play an important role for the apoptosis
response. This possibility is further supported by the ob-
servation that cells with a low phagocytic capacity did not
undergo apoptosis under conditions in which macrophage
cell lines demonstrated this response. Since cell death was
inhibited completely by the addition of microparticle-free
supernatant but not by using microfilters, however, it is
possible that, during culture, microparticles release frag-
ments with membraneous phospholipids which may pass
the filter to interact with macrophages due to their smaller
size.
Together with previous observations on the activity of
microparticles, these findings suggest that microparticles
induce apoptosis by a dysregulation of phospholipid-
arachidonate pathway rather than interaction with a spe-
cific surface receptor. Microparticles represent a population
of vesicles of 200–700 nm size surrounded by a packed
phospholipid bilayer originating from the cell membranes.
These particles can interact with, and enter target, cells dur-
ing phagocytosis. In this process, a rapid redistribution of
arachidonate from releasable pools by phospholipases A2
may increase the levels of free unesterified arachidonic acid.
This lipid mediator appears to be an important signal both
for inhibiting cell proliferation and inducing apoptosis by
regulating gene expression, controlling transcription factors,
and generation of inflammatory mediators [40–42].
Among its actions, arachidonic acid can activate acid sph-
ingomyelinase to metabolize sphingomyelin into C2/C16-
ceramides and, thereby, initiate the apoptotic cascade. Stud-
ies on a variety of systems indicate that maintenance of
arachidonate levels is important for homeostasis and a nec-
essary condition for cell growth and survival. It is of inter-
est, in this regard, that cancer cells depleted of arachidonate
display an increased resistance to apoptosis. Furthermore,
the intracellular accumulation of arachidonic acid following
treatment with nonsteroidal anti-inflammatory drugs may be
beneficial in treatment of colorectal cancer by leading to
the generation of ceramides and, ultimately, the induction of
apoptosis [11, 14].
Using phosphatidylinositol-3,5-biphosphate (Ptins(3,
5)BP), a specific inhibitor of the arachidonate-dependent
enzyme acid sphingomyelinase, we identified sphingomyelin
as a key mediator in microparticle-induced apoptosis. Thus,
in our experiments, Ptins(3,5)BP reduced the occurrence
of apoptosis in microparticle-treated macrophage cells in
a dose-dependent manner without affecting the spontaneous
rate of apoptosis in these cells. To clarify further the mech-
anisms of this response, we investigated the role of MAP-
Kinases. These kinases could play a role in apoptosis if,
during particle interaction with the target cell, membrane
phospholipids from microparticles are cleaved by the en-
zyme phospholipase A2. In this context, the cytosolic iso-
form of phospholipase A2 shows a strong preference for sn-
2 bond arachidonic acid over other fatty acids and appears
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Fig. 7 Proposed mechanism of apoptosis-induction of microparti-
cles in phagocytosing cells by phospholipid-arachidonate-ceramide re-
modeling. The phagocytosis of microparticles leads to an increased
cellular content of 1-ether-linked membrane phospholipids, which are
cleaved by phospholipases A2 into arachidonic acid. Arachidonic acid
is a strong activator of acid sphingomyelinase that metabolizes sphin-
gomyelin in pro-apoptotic ceramides. Blocking this cycle by inhibition
of ERK1/MEK1 (PD98059) or by inhibition of the acid sphingomyeli-
nase [Ptins(3,5)BP] abrogates the microparticle-induced apoptosis re-
sponse in target cells
to mediate stimulus-coupled release of arachidonate during
inflammatory processes [43]. Furthermore, serine phospho-
acceptor sites, which are phosphorylated by MAP-Kinases,
are essential for the stimulus-coupled activation of cytosolic
phospholipase A2 [44, 45].
As shown in these experiments, microparticles strongly
induced the phosphorylation of ERK1/2, a tyrosine kinase
central to the operation of the MAP-Kinase pathway, in
a time-dependent manner. In addition, the specific MAP-
Kinase inhibitor PD098059 caused a marked reduction in
the population of early apoptotic cells induced by treatment
of macrophages with microparticles, further supporting the
role of this pathway. Based on these results, we propose that
microparticles induce apoptosis in phagocytes by disturb-
ing the lipid content of cells, in particular, by increasing the
concentration free arachidonic acid (Fig. 7). Arachidonic
acid in turn can stimulate the activity of acid sphingomyeli-
nase to generate ceramides that trigger apoptosis. Since mi-
croparticles can activate this response, it appears likely that
these structures provide phospholipids substrates that are
preferentially cleaved by phospholipases to provide a source
of arachidonate. This preference may result from the subcel-
lular location of the particles during phagocytosis or other
cellular changes occurring during this process.
As reported previously [10], in clinical situations with
high levels of circulating microparticles or excessive apop-
tosis such as malignancies, autoimmune syndromes and
chemotherapy, microparticles might set off an amplification
loop of apoptosis in phagocytosing cells thus suppressing
the immune response by loss of macrophages. By describing
an important intracellular pathway of this mechanism, our
results might help to identify novel therapeutic strategies to
overcome complications of these severe clinical entities.
In summary, these studies demonstrate that microparticles
from immune cells can induce apoptosis in macrophage cell
lines as well as primary macrophages. This process can be
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inhibited by interfering with the phospholipid-arachidonate
remodelling, suggesting that the apoptotic cascade induced
by interaction of microparticles with phagocytosing cells is
mediated by the arachidonate-ceramide pathway. We have
suggested previously that the ingestion of microparticles
may represent a novel and specific mechanism for the in-
duction of apoptosis in macrophages that could be operative
in a number of clinical settings, including sepsis, systemic
inflammation and malignancy. In these settings, the extent of
microparticle release may increase, thereby causing subse-
quent immune system derangement [10]. Here, we propose
a molecular mechanism underlying this phenomenon. More-
over, our results emphasize the importance of lipids in the
cross-talk of immune cells that can operate with both in-
tact cells as well as subcellular vesicles. Future studies will
investigate the potency of these particles as a source of mem-
brane lipids that can trigger cellular responses.
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